Physician profile
Robin Jacob
NPI 1538516059
$4,992.37
in general payments reported to CMS, 2019-2025
19 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $354 · 2021: $770 · 2022: $1,889 · 2023: $1,101 · 2024: $246 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,057.60 | 2021-2025 | Avvigo Guidance System |
| Medtronic, INC. | $745.62 | 2022-2023 | Corevalve Evolut R |
| Chiesi USA, INC. | $541.02 | 2022-2025 | Kengreal, Cleviprex |
| Astellas Pharma US INC | $497.70 | 2019-2021 | |
| Abbott Laboratories | $322.22 | 2021-2025 | Xience Skypoint, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.59 | 2020-2023 | Lifevest |
| Biotronik INC. | $236.58 | 2022 | |
| Shockwave Medical, INC | $203.69 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $177.44 | 2023 | |
| Heartflow, INC. | $157.20 | 2025 | |
| Novartis Pharmaceuticals Corporation | $151.15 | 2021-2023 | |
| Cardiovascular Systems INC. | $146.64 | 2022 | |
| Abiomed | $138.07 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $108.43 | 2020-2023 | Andexxa, Farxiga |
| Terumo Medical Corporation | $90.84 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $75.73 | 2021 | |
| Pfizer INC. | $53.22 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $34.64 | 2020-2021 | |
| Lantheus Medical Imaging, INC. | $14.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.